Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chest Pain | 28 | 2022 | 205 | 9.770 |
Why?
|
| Acute Coronary Syndrome | 20 | 2022 | 167 | 6.280 |
Why?
|
| Emergency Service, Hospital | 30 | 2021 | 444 | 5.520 |
Why?
|
| Myocardial Infarction | 17 | 2021 | 466 | 4.630 |
Why?
|
| Troponin | 16 | 2020 | 101 | 3.360 |
Why?
|
| Patient Discharge | 7 | 2019 | 204 | 1.910 |
Why?
|
| Decision Support Techniques | 5 | 2020 | 131 | 1.890 |
Why?
|
| Critical Pathways | 6 | 2018 | 47 | 1.810 |
Why?
|
| Hospitalization | 4 | 2021 | 476 | 1.690 |
Why?
|
| Risk Assessment | 16 | 2021 | 1424 | 1.580 |
Why?
|
| Electrocardiography | 14 | 2020 | 624 | 1.560 |
Why?
|
| Emergency Medical Services | 5 | 2022 | 183 | 1.350 |
Why?
|
| Humans | 58 | 2022 | 32284 | 1.300 |
Why?
|
| Adult | 30 | 2022 | 9263 | 1.300 |
Why?
|
| Middle Aged | 33 | 2022 | 11843 | 1.190 |
Why?
|
| Troponin T | 2 | 2021 | 92 | 1.140 |
Why?
|
| Male | 40 | 2022 | 19434 | 1.100 |
Why?
|
| Decision Making | 5 | 2016 | 190 | 1.070 |
Why?
|
| Female | 38 | 2022 | 19954 | 1.070 |
Why?
|
| Prospective Studies | 16 | 2022 | 2320 | 1.050 |
Why?
|
| Emergency Medicine | 5 | 2014 | 110 | 1.030 |
Why?
|
| Health Personnel | 2 | 2018 | 113 | 1.020 |
Why?
|
| Aged | 27 | 2021 | 10257 | 1.010 |
Why?
|
| Catheterization, Peripheral | 3 | 2013 | 27 | 1.010 |
Why?
|
| Ultrasonography, Interventional | 3 | 2013 | 55 | 0.990 |
Why?
|
| Cardiology Service, Hospital | 3 | 2015 | 19 | 0.920 |
Why?
|
| Heart | 4 | 2022 | 177 | 0.850 |
Why?
|
| Acute Disease | 6 | 2021 | 253 | 0.820 |
Why?
|
| Cardiovascular Diseases | 3 | 2021 | 1159 | 0.810 |
Why?
|
| Internship and Residency | 4 | 2014 | 317 | 0.800 |
Why?
|
| Coronary Angiography | 5 | 2018 | 159 | 0.760 |
Why?
|
| Predictive Value of Tests | 9 | 2020 | 880 | 0.750 |
Why?
|
| Cohort Studies | 8 | 2021 | 1840 | 0.730 |
Why?
|
| Clinical Competence | 4 | 2012 | 329 | 0.700 |
Why?
|
| Exercise Test | 7 | 2019 | 218 | 0.690 |
Why?
|
| North Carolina | 9 | 2020 | 1299 | 0.680 |
Why?
|
| Educational Measurement | 2 | 2012 | 113 | 0.660 |
Why?
|
| Risk Factors | 11 | 2021 | 3938 | 0.660 |
Why?
|
| Evidence-Based Medicine | 1 | 2022 | 212 | 0.640 |
Why?
|
| United States | 11 | 2021 | 4079 | 0.630 |
Why?
|
| Myocardial Revascularization | 3 | 2018 | 34 | 0.620 |
Why?
|
| Ambulances | 1 | 2020 | 11 | 0.620 |
Why?
|
| Transportation of Patients | 1 | 2020 | 22 | 0.610 |
Why?
|
| Mortality | 1 | 2020 | 122 | 0.610 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 851 | 0.590 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 394 | 0.580 |
Why?
|
| Time Factors | 10 | 2020 | 2196 | 0.580 |
Why?
|
| Health Plan Implementation | 1 | 2018 | 18 | 0.560 |
Why?
|
| Clinical Protocols | 2 | 2016 | 77 | 0.560 |
Why?
|
| Ethnic Groups | 1 | 2020 | 450 | 0.550 |
Why?
|
| Chemokine CCL2 | 1 | 2018 | 42 | 0.540 |
Why?
|
| Point-of-Care Systems | 3 | 2020 | 44 | 0.540 |
Why?
|
| Problem-Based Learning | 1 | 2018 | 29 | 0.530 |
Why?
|
| Interdisciplinary Communication | 1 | 2018 | 59 | 0.530 |
Why?
|
| Public Health | 1 | 2018 | 91 | 0.530 |
Why?
|
| Certification | 1 | 2018 | 29 | 0.530 |
Why?
|
| Education, Distance | 1 | 2018 | 19 | 0.530 |
Why?
|
| Qualitative Research | 1 | 2018 | 180 | 0.520 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 52 | 0.520 |
Why?
|
| Follow-Up Studies | 8 | 2020 | 2238 | 0.500 |
Why?
|
| Troponin C | 1 | 2017 | 8 | 0.500 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 167 | 0.500 |
Why?
|
| Length of Stay | 4 | 2015 | 321 | 0.490 |
Why?
|
| Odds Ratio | 4 | 2020 | 455 | 0.490 |
Why?
|
| Students, Medical | 1 | 2018 | 126 | 0.480 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 88 | 0.460 |
Why?
|
| Health Care Costs | 1 | 2016 | 122 | 0.450 |
Why?
|
| Death | 1 | 2015 | 51 | 0.450 |
Why?
|
| Sensitivity and Specificity | 4 | 2020 | 555 | 0.440 |
Why?
|
| Robotics | 1 | 2016 | 133 | 0.430 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 427 | 0.430 |
Why?
|
| Observation | 2 | 2013 | 22 | 0.410 |
Why?
|
| Diagnosis, Differential | 5 | 2020 | 502 | 0.410 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 755 | 0.400 |
Why?
|
| Emergency Treatment | 1 | 2013 | 37 | 0.380 |
Why?
|
| Crowding | 2 | 2014 | 5 | 0.370 |
Why?
|
| Retrospective Studies | 8 | 2021 | 3612 | 0.370 |
Why?
|
| Logistic Models | 4 | 2020 | 743 | 0.360 |
Why?
|
| Coronary Vessels | 1 | 2013 | 173 | 0.350 |
Why?
|
| Education, Medical | 1 | 2012 | 69 | 0.350 |
Why?
|
| Ultrasonography | 2 | 2011 | 394 | 0.340 |
Why?
|
| Cardiac Electrophysiology | 1 | 2011 | 3 | 0.340 |
Why?
|
| Teaching | 1 | 2011 | 60 | 0.330 |
Why?
|
| Curriculum | 1 | 2012 | 203 | 0.320 |
Why?
|
| Prognosis | 6 | 2020 | 1529 | 0.320 |
Why?
|
| Electrolytes | 1 | 2010 | 11 | 0.320 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2010 | 5 | 0.320 |
Why?
|
| Education, Medical, Graduate | 1 | 2011 | 130 | 0.320 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2010 | 12 | 0.310 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2011 | 75 | 0.310 |
Why?
|
| Incidence | 4 | 2018 | 1244 | 0.300 |
Why?
|
| Alcoholic Intoxication | 1 | 2009 | 28 | 0.290 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2013 | 906 | 0.290 |
Why?
|
| Hispanic Americans | 2 | 2020 | 772 | 0.280 |
Why?
|
| Algorithms | 4 | 2019 | 537 | 0.280 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2009 | 88 | 0.280 |
Why?
|
| Seat Belts | 1 | 2008 | 18 | 0.280 |
Why?
|
| Triage | 2 | 2021 | 68 | 0.270 |
Why?
|
| Balanitis | 1 | 2007 | 3 | 0.260 |
Why?
|
| Penile Diseases | 1 | 2007 | 4 | 0.260 |
Why?
|
| Soft Tissue Infections | 1 | 2007 | 6 | 0.260 |
Why?
|
| Abscess | 1 | 2007 | 28 | 0.260 |
Why?
|
| Internet | 1 | 2008 | 202 | 0.240 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 1485 | 0.230 |
Why?
|
| Survival Rate | 2 | 2018 | 892 | 0.210 |
Why?
|
| Age Factors | 2 | 2018 | 1179 | 0.210 |
Why?
|
| Postural Balance | 1 | 2016 | 142 | 0.210 |
Why?
|
| Pesticides | 1 | 2016 | 135 | 0.210 |
Why?
|
| Occupational Exposure | 1 | 2016 | 159 | 0.210 |
Why?
|
| Transients and Migrants | 1 | 2016 | 197 | 0.200 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 198 | 0.200 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 24 | 0.180 |
Why?
|
| Thorax | 1 | 2022 | 32 | 0.180 |
Why?
|
| Adolescent | 4 | 2020 | 3521 | 0.160 |
Why?
|
| Troponin I | 1 | 2020 | 20 | 0.160 |
Why?
|
| Rural Population | 1 | 2021 | 217 | 0.150 |
Why?
|
| Medical History Taking | 2 | 2017 | 39 | 0.150 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 180 | 0.150 |
Why?
|
| Sex Factors | 1 | 2020 | 656 | 0.140 |
Why?
|
| Ohio | 1 | 2018 | 63 | 0.140 |
Why?
|
| Interviews as Topic | 1 | 2018 | 195 | 0.140 |
Why?
|
| European Continental Ancestry Group | 1 | 2020 | 1076 | 0.120 |
Why?
|
| Cost Savings | 1 | 2016 | 34 | 0.120 |
Why?
|
| Thrombolytic Therapy | 1 | 2016 | 63 | 0.120 |
Why?
|
| Young Adult | 3 | 2020 | 2652 | 0.120 |
Why?
|
| Costs and Cost Analysis | 1 | 2016 | 106 | 0.120 |
Why?
|
| Hospitals | 1 | 2016 | 95 | 0.120 |
Why?
|
| Disease Management | 1 | 2016 | 129 | 0.120 |
Why?
|
| Risk | 1 | 2016 | 305 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2016 | 138 | 0.110 |
Why?
|
| Cardiology | 1 | 2016 | 104 | 0.110 |
Why?
|
| Echocardiography, Stress | 1 | 2015 | 23 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 548 | 0.100 |
Why?
|
| African Americans | 1 | 2020 | 1335 | 0.100 |
Why?
|
| Efficiency, Organizational | 1 | 2013 | 16 | 0.100 |
Why?
|
| Angina Pectoris | 1 | 2013 | 20 | 0.100 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 62 | 0.100 |
Why?
|
| Positive-Pressure Respiration | 2 | 2003 | 14 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 3896 | 0.090 |
Why?
|
| Patient Satisfaction | 2 | 2014 | 230 | 0.090 |
Why?
|
| Registries | 1 | 2013 | 294 | 0.090 |
Why?
|
| Coronary Care Units | 1 | 2011 | 6 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2011 | 470 | 0.090 |
Why?
|
| Knowledge | 1 | 2011 | 13 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2011 | 141 | 0.080 |
Why?
|
| Louisiana | 1 | 2011 | 12 | 0.080 |
Why?
|
| Hospitals, Urban | 1 | 2011 | 12 | 0.080 |
Why?
|
| Hospitals, University | 1 | 2011 | 27 | 0.080 |
Why?
|
| Health Expenditures | 1 | 2011 | 66 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 128 | 0.080 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2010 | 1 | 0.080 |
Why?
|
| Lymphopoiesis | 1 | 2010 | 4 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2013 | 1211 | 0.080 |
Why?
|
| Acid-Base Equilibrium | 1 | 2010 | 9 | 0.080 |
Why?
|
| Bicarbonates | 1 | 2010 | 11 | 0.080 |
Why?
|
| Solutions | 1 | 2010 | 39 | 0.080 |
Why?
|
| Sodium Chloride | 1 | 2010 | 25 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2010 | 77 | 0.080 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 38 | 0.070 |
Why?
|
| Double-Blind Method | 1 | 2010 | 566 | 0.070 |
Why?
|
| Infant Equipment | 1 | 2008 | 1 | 0.070 |
Why?
|
| Ethanol | 1 | 2010 | 195 | 0.070 |
Why?
|
| Job Application | 1 | 2008 | 6 | 0.070 |
Why?
|
| Comorbidity | 1 | 2009 | 563 | 0.070 |
Why?
|
| Data Collection | 1 | 2008 | 171 | 0.070 |
Why?
|
| Foreskin | 1 | 2007 | 8 | 0.070 |
Why?
|
| Drainage | 1 | 2007 | 65 | 0.060 |
Why?
|
| African Continental Ancestry Group | 1 | 2008 | 338 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2016 | 858 | 0.050 |
Why?
|
| Pulmonary Edema | 1 | 2003 | 12 | 0.050 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2003 | 59 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 69 | 0.050 |
Why?
|
| Respiratory Distress Syndrome, Adult | 1 | 2003 | 50 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2010 | 3410 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2003 | 1073 | 0.050 |
Why?
|
| Liquid Ventilation | 1 | 2002 | 2 | 0.040 |
Why?
|
| Child | 1 | 2008 | 2446 | 0.040 |
Why?
|
| Ventilators, Mechanical | 1 | 2002 | 6 | 0.040 |
Why?
|
| Respiratory Insufficiency | 1 | 2002 | 60 | 0.040 |
Why?
|
| Lung | 1 | 2002 | 264 | 0.040 |
Why?
|
| Fluorocarbons | 1 | 1999 | 21 | 0.040 |
Why?
|
| Respiration | 1 | 1999 | 30 | 0.040 |
Why?
|
| Wakefulness | 1 | 1999 | 25 | 0.040 |
Why?
|
| Intubation, Intratracheal | 1 | 1999 | 56 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 1999 | 98 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2019 | 340 | 0.030 |
Why?
|
| Patient Transfer | 1 | 2016 | 41 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 161 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2014 | 148 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 183 | 0.020 |
Why?
|
| Animals | 4 | 2010 | 8165 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 169 | 0.020 |
Why?
|
| Physical Examination | 1 | 2013 | 83 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2013 | 135 | 0.020 |
Why?
|
| Radiography | 1 | 2013 | 358 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 26 | 0.020 |
Why?
|
| Women's Health | 1 | 2013 | 230 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 773 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2010 | 4 | 0.020 |
Why?
|
| Echocardiography | 1 | 2011 | 190 | 0.020 |
Why?
|
| Myocardium | 1 | 2011 | 184 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2010 | 64 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 112 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2010 | 184 | 0.020 |
Why?
|
| Cytokines | 1 | 2010 | 236 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 246 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 821 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 776 | 0.020 |
Why?
|
| Mice | 1 | 2010 | 2544 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2003 | 7 | 0.010 |
Why?
|
| Peroxidase | 1 | 2003 | 27 | 0.010 |
Why?
|
| Random Allocation | 1 | 2003 | 246 | 0.010 |
Why?
|
| Sheep | 1 | 2002 | 194 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 896 | 0.010 |
Why?
|
| Instillation, Drug | 1 | 1999 | 2 | 0.010 |
Why?
|
| Lung Volume Measurements | 1 | 1999 | 4 | 0.010 |
Why?
|
| Rats | 1 | 2003 | 1892 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1999 | 70 | 0.010 |
Why?
|
| Tracheostomy | 1 | 1999 | 28 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1999 | 192 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 214 | 0.010 |
Why?
|